Biointron Funding: $64M Raised, Series B (2022)

Biointron funding overview

Biointron is based in Shanghai, China. Biointron has raised $64M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Biointron runs through 2022; nothing later has been disclosed. Investors on record include BeFor Capital, Co-Stone Capital, Gaorong Capital, Haitong Securities, Jiangsu Tech Industry Investment. 5 distinct backers are named across the disclosed rounds.

Biointron at a glance

Total raised: $64M
Latest round: Series B
Latest round date: January 2022
Headquarters: Shanghai, China
Notable investors: BeFor Capital, Co-Stone Capital, Gaorong Capital, Haitong Securities, Jiangsu Tech Industry Investment

Frequently asked about Biointron funding

How much has Biointron raised?: Biointron has raised $64M in total disclosed funding across the rounds on record.
Who has invested in Biointron?: BeFor Capital, Co-Stone Capital, Gaorong Capital, Haitong Securities, Jiangsu Tech Industry Investment are named among the investors backing Biointron.
What was the latest Biointron funding round?: The most recent disclosed round is a Series B, announced in January 2022.
Where is Biointron based?: Biointron is based in Shanghai, China.
When did Biointron last raise?: The last disclosed Biointron round closed in January 2022 at Series B.

We update the Biointron record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shanghai and their backers are listed below.

Biointron Funding: $64M Raised, Series B (2022)

Biointron funding overview

Biointron at a glance

Frequently asked about Biointron funding

Companies related to Biointron (18)

Browse related funding lists (6)